AHMM is working with Imperial College Healthcare NHS Trust on proposals for a world class clinical research facility, as part of the St Mary’s Hospital Masterplan.

The Fleming Centre will be one of the first development initiatives to support the Trust’s life sciences ambitions, ahead of the wider site regeneration. It will be a major new contributor to the UK’s vision that by 2024 antimicrobial resistance (AMR) will be effectively contained, controlled, and mitigated. It will be a place of discovery, innovation and, above all, the that drives global change, from the birthplace of antibiotics.